Showing results (1351-1360 of 8,142) with videos related to

Sort By:
Pageof 815
Haematologica|January 26, 2013
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemiaAlan H Shih, Stephen S Chung, Emily K Dolezal, et al.
Haematologica|January 26, 2013
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trialDavid I Marks, Anthony V Moorman, Lucy Chilton, et al.
Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.
Haematologica|December 18, 2012
Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysisAnnalisa Ruggeri, Vanderson Rocha, Emeline Masson, et al.
Haematologica|December 18, 2012
Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trialMeletios A Dimopoulos, Michel Delforge, Roman Hájek, et al.
Haematologica|December 18, 2012
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndromeBenedetta Costantini, Shahram Y Kordasti, Austin G Kulasekararaj, et al.
Haematologica|December 18, 2012
Iron increases the susceptibility of multiple myeloma cells to bortezomibAlessandro Campanella, Paolo Santambrogio, Francesca Fontana, et al.
Haematologica|December 18, 2012
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomasAgnieszka Korfel, Thomas Elter, Eckhard Thiel, et al.
Haematologica|April 26, 2012
Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemiaAziz Nazha, Jorge Cortes, Stefan Faderl, et al.
Haematologica|February 29, 2012
Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapyMuhammad Ameer Saif, Brian W Bigger, Karen E Brookes, et al.
Pageof 815